Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,244 | 78,552 | 54,589 | 78,228 | 85,139 |
| Marketable Securities | 406,881 | 248,240 | 263,875 | 213,722 | 180,505 |
| Receivables | 46,143 | 44,013 | 38,988 | 47,530 | 42,573 |
| Inventories | 68,542 | 66,690 | 59,666 | 58,296 | 60,238 |
| TOTAL | $658,520 | $455,823 | $431,594 | $408,557 | $378,847 |
| Non-Current Assets | |||||
| PPE Net | 125,527 | 113,297 | 108,105 | 104,681 | 104,856 |
| Investments And Advances | 58,019 | 19,191 | 42,099 | 75,769 | 82,129 |
| Intangibles | 198,034 | 200,001 | 201,968 | 203,934 | 205,901 |
| Other Non-Current Assets | 180,169 | 77,799 | 37,613 | 38,124 | 35,756 |
| TOTAL | $561,749 | $410,288 | $389,785 | $422,508 | $428,642 |
| Total Assets | $1,220,269 | $866,111 | $821,379 | $831,065 | $807,489 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,008 | 9,160 | 15,850 | 12,799 | 16,064 |
| Accrued Expenses | 60,403 | 47,684 | 44,717 | 70,427 | 61,002 |
| Other current liabilities | 5,406 | 4,504 | 14,041 | 18,179 | 13,591 |
| TOTAL | $86,272 | $70,583 | $80,313 | $107,673 | $95,838 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 549,307 | 407,380 | 367,029 | 368,448 | 365,489 |
| TOTAL | $549,307 | $407,380 | $367,029 | $368,448 | $365,489 |
| Total Liabilities | $635,579 | $477,963 | $447,342 | $476,121 | $461,327 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,444 | 42,742 | 42,121 | 42,033 | 41,731 |
| Common Shares | 43 | 43 | 42 | 42 | 42 |
| Retained earnings | -268,390 | -398,509 | -391,239 | -399,398 | -394,510 |
| Other shareholders' equity | 847 | 1,490 | -1,046 | 322 | 447 |
| TOTAL | $584,690 | $388,148 | $374,037 | $354,944 | $346,162 |
| Total Liabilities And Equity | $1,220,269 | $866,111 | $821,379 | $831,065 | $807,489 |